Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Paper Retractions Unveil China Academic Fake Review Scams

This article was originally published in PharmAsia News

Executive Summary

Out of 43 papers retracted by BioMed Central due to an inappropriate and manipulative peer review process, 41 are from China, involving 38 top hospitals around the country. Some of the affected research papers relate to drugs, including an anti-platelet agent and a novel compound for hepatocellular carcinoma.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC088750

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel